Please login to the form below

Not currently logged in
Email:
Password:

Ex-J&J exec Denice Torres joins bluebird bio’s board

Torres brings over 25 years of executive management experience to the role

Ex-Johnson & Johnson executive Denice Torres (pictured above) has been appointed to bluebird bio’s board of directors.

During her time at J&J, Torres held several executive leadership roles including president of McNeil Consumer Healthcare and president of Janssen Pharmaceuticals, CNS.

She also served as chief strategy and transformation officer for J&J’s medical device division. Torres has expertise in leading large-scale transformations, from strategy to execution.

Prior to J&J, Torres worked for 14 years at Eli Lilly in a range of commercial roles, including leading US women’s health, global neuroscience and growth hormone. In 2015, she was named Healthcare Businesswomen’s Association’s (HBA) woman of the year.

In addition to her professional experience, Torres is the founder of The Mentoring Place, a volunteer platform that focuses on helping to accelerate the careers of women.

She is also the founder of The Ignited Company, a consulting firm specialising in the development of high-performing individuals and teams.

“We’re excited to welcome Denice to the Board to help guide bluebird as we reach the next stage in our evolution,” said Nick Leschly, president and chief executive officer at bluebird.

“Denice brings valuable perspective and exceptional industry insights based on over 25 years of executive management experience in pharmaceuticals, medical device and consumer healthcare for global organisations.

“In addition, she has a deep understanding of the benefit of cultivating people, diversity and culture to strengthen internal collaboration and propel companies forward. We look forward to her contributions as we work to deliver critical therapies to our patients,” he added,

Article by
Lucy Parsons

12th August 2020

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...